Sapha Barkati and Marina Klein receive the 2023 FMSQ prize for best research paper
Their highly cited publication in the New England Journal of Medicine describes the unique clinical presentation of mpox
Triple-negative breast cancer: a new clinical study opens new and promising therapeutic prospects
The RI-MUHC will host a new Phase 3 randomized clinical trial called TROPION-Breast04, as announced today...
The 2023 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz
Code Life Research Awards Ceremony
Researchers at the RI-MUHC receive support from the Montreal General Hospital Foundation and the Cedars Cancer Foundation
RI-MUHC laboratory wins the International Freezer Challenge at McGill University
This impressive win for the Specimen Processing Laboratory at the Centre for Innovative Medicine is part of a push for greater...
Record turnout for Summer Student Research Day at the RI-MUHC
This annual event gives summer students a unique opportunity to present their projects to the research community
Panel discussion at the RI-MUHC marks International Day of People Living with Disabilities
Experts and advocates joined the RI-MUHC community to discuss integrating people with disabilities into work...
Significant funding to maximize access and drive excellence in clinical trials in Quebec and Canada
RI-MUHC researchers will lead or co-lead multiple projects awarded a total of $55 million from the Canadian Institutes...
Triple-negative breast cancer: the RI-MUHC enrolls first patients in international Phase 3 clinical trial
The first participants in this large study were recently selected at the Cedars Cancer Centre of the MUHC.
The 2022 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz